Speaking Faculty

ADVISORY BOARD


Ana Carolina Quarezemim Global Monitoring Operations Head for Latin America, NOVARTIS ONCOLOGY Brazil	Victor Molina Viamonte MDD, FACC, President, CAOIC ARGENTINA	Silvio Klimovsky MD, MBA, Head of Clinical Operations Argentina and Uruguay, PFIZER ARGENTINA	Charles Schmidt MD, General Manager, Latin America, MEDPACE, Vice President, ABRACRO

Juan Carlos Groppa Director of Logistics Department, BAGA LABORATORIES	Mitchell Katz PhD, VP, Global Clinical Development, EISAI USA	Eduardo Motti Regional Head Clinical Operations, PFIZER BRAZIL	Celso Arabetti President, SOCIETY OF CLINICAL RESEARCH-BUENOS AIRES, ARGENTINA

2011 SPEAKER FACULTY

Adriano Lago, MBA, MSc, Gerente Pesquisa Clínica FUNDAÇÃO PIO XII - HOSPITAL DE CÂNCER DE BARRETOS
Augustina Visio, Directora de Evaluacion, Departmante de, ANMAT-ARGENTINAL
Ana Carolina Quarezemim, GMO Country Head, NOVARTIS ONCOLOGY-BRAZIL
Ariette van Strien, VP Global Business Development, MARKEN
Roberta Ferreira,BSN, Associate Director Global Quality Regulatory Compliance Clinical Trials and Safety, BRISTOL-MYERS SQUIBB
Carlos Augusto, Senior Manager-Brazil Clinical Operations, ELI LILLY-BRAZIL
Dr. Jaderson Lima, Director for Medical and Scientific Alliance, SANOFI-AVENTIS-BRAZIL
Carlos Burger, Legal Counsel, Acting Secretary, ETHICS COMMITTEE, AT MINISTRY OF HEALTH-BUENOS AIRES PROVINCE, ARGENTINA
Celso Arabetti, President, SOCIETY OF CLINICAL RESEARCH-BUENOS AIRES
Carlos Adriano, Silva dos Santos Comissao Nacional de Etica em Pesquia, CONEP
Charles Schmidt, MD, PhD, Senior Consultant Eurotrials; Coordinator and Professor of the Post-Graduation Program in Clinical Research, SANTA CASA MEDICAL SCHOOL – SAO PAULO, Brazil and Founder and Vice-president of ABRACRO
Daniele Argentina, BSN,RN, Head of Regulatory & Nursing Dept, CCBR BRASIL
Luciano Lobo, Coordenador Técnico Administrativo – Tecnical Administrative Coordenator, Pró Genéricos – Associação Brasileira das Indústrias de Medicamentos Genéricos
Diego Martin Glancszpigel, Corporate Vice President, PAREXEL INTERNATIONAL-BRAZIL
Eduardo Motti, Regional Head Clinical Operations, PFIZER- BRAZIL
Fernanda Yamaguchi Aoki, Clinical Support Director Latin America, ASTRAZENECA
Fanny Nascimento Moura, Sanitary Vigilance and Regulation Specialist,ANVISA
Fidela L. Moreno, MD, Vice President, Global Development Operations, Clinical Site Management and Monitoring, ALLERGAN
Greg Jones, Chief Technology OfficerORACLE LIFE SCIENCES
Glauce Nunes, Director, Clinical Operations Latin AmericaRPS
Gustavo Kesselring, MD, Director Clinical Operations, Clinical Research Center, OSWALDO CRUZ HOSPITAL, São Paulo Brazil
Juan Luis Yrivarren Md, Research Director, Clinical Research Site Ricardo PALMA-CLINICA RICARDO PALMA Peru
Juan Pablo von Arx, MD, Coordinator of the Central COMMITTEE OF ETHICS, PROVINCE OF BUENOS AIRES
Ligia Terne, Sr. Trainer, Clinical Programs, RPS DO BRASIL SERVICOS DE PESQUISA
Luis Augusto Russo MD PhD, Director, CCBR BRASIL
Marcelo Belgrano, Clinical Study Manager, NOVARTIS-ARGENTINA
Bianca Dalle Olle, Site Monitor Manager, BRISTOL-MYERS SQUIBB BRAZIL
Ola Strandberg, Vendor Liaison Officer, Uppsala Monitoring, part of WHO INTERNATIONAL DRUG MONITORING PROGRAM
Pilar Rodriguez, Regional Country Study Manager, ELI LILLY
Tomasz Sablinski, MD, Managing Director, Head of Development, CELTIC THERAPEUTICS
Valentina Jaramillo, Founder, HEALTH CARE SOCIAL MEDIA LATIN AMERICA
Marcos Thedim D. Cancella, MD, Legal Director and Compliance Officer, MERCK-BRAZIL
Jorge Raimundo, President, INTERFARMA
Victor Molina Viamonte, MD, FACC, President, CAOIC-ARGENTINA
Steve Yang, Vice President, Head of R&D, Asia & Emerging Markets, ASTRAZENECA
Lia Cristina Tavares Maluf, Project Director, COREWARE
Cecilia Matos-Rosa, CCRP Sr. QA Auditor – GCP, AMAG PHARMACEUTICALS, INC.
Martin Valania, VP of Corporate Quality As surance & Compliance, PHARMANET
Carolina Errobidart, Clinical Data Quality Manager, BRISTOL-MYERS SQUIBB-ARGENTINA
Matilde Damian, Director, Clinical Research, BRISTOL-MYERS-SQUIBB, MEXICO AND CENTRAL AMERICA
Vania Solda de Jesus, Gerente de Projetos Clínicos Internacionais, PRODUTO ROCHE QUIMICOS E FARMACEUTICOS S.A.